Tumor cell death can promote the infiltration of immune cells and activate antitumor immune responses through the expression of damage-related molecular patterns such as calreticulin and the release of immune effectors, such as tumor antigens, high mobility group box 1, ATP, and heat shock proteins (HSP70 and HSP90). The gene discussed is HMGB1; the disease is neoplasm.